Boris Minev
Impact in
- Genetics top 2%
- Mesenchymal stem cell research
- Virus-based gene therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 26
- Immunotherapy and Immune Responses 22
- Oncology 22
- CAR-T cell therapy research 9
- Cancer Cells and Metastasis 5
- Co-authors
- Neil H Riordan (13 shared papers)Thomas E. Ichim (12 shared papers)Robert J. Harman (5 shared papers)Amit N. Patel (6 shared papers)Aladar A. Szalay (12 shared papers)Hüseyin Firat (1 shared paper)Maurizio Zanetti (1 shared paper)Wenxue Ma (10 shared papers)
- Journals
- Journal of Translational Medicine (19 papers)Journal of Clinical Oncology (3 papers)European Journal of Immunology (2 papers)Molecular Therapy — Oncolytics (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Boris Minev
60 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Genetics 469
- Immunology 727
- Oncology 449
- Biotechnology 125
- Molecular Biology 750
Countries citing papers authored by Boris Minev
This map shows the geographic impact of Boris Minev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Minev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Minev more than expected).
Fields of papers citing papers by Boris Minev
This network shows the impact of papers produced by Boris Minev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Minev. The network helps show where Boris Minev may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Minev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 239 | |
| 2 | 2000 | 205 | |
| 3 | 2007 | 110 | |
| 4 | 2009 | 109 | |
| 5 | 2014 | 88 | |
| 6 | 2020 | 84 | |
| 7 | 2008 | 81 | |
| 8 | Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice. | 1994 | 76 |
| 9 | 2010 | 73 | |
| 10 | 2010 | 66 | |
| 11 | 2012 | 52 | |
| 12 | 2010 | 50 | |
| 13 | 2006 | 47 | |
| 14 | 2009 | 40 | |
| 15 | 2018 | 39 | |
| 16 | 2012 | 36 | |
| 17 | 2019 | 33 | |
| 18 | 2012 | 33 | |
| 19 | 2000 | 33 | |
| 20 | A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. | 2000 | 32 |
About Boris Minev
Boris Minev is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Genetics, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (22 papers), Virus-based gene therapy research (13 papers), CAR-T cell therapy research (9 papers), RNA Interference and Gene Delivery (8 papers), Cancer Research and Treatments (8 papers), Mesenchymal stem cell research (7 papers), vaccines and immunoinformatics approaches (7 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Genetics (469 citations), Immunology (727 citations), Oncology (449 citations), Biotechnology (125 citations) and Molecular Biology (750 citations). Boris Minev has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Neil H Riordan, Thomas E. Ichim, Robert J. Harman, Amit N. Patel, Aladar A. Szalay, Hüseyin Firat, Maurizio Zanetti, Wenxue Ma, Jason Hipp and Joseph D. Schmidt. Their work appears in journals such as Journal of Translational Medicine, Journal of Clinical Oncology, European Journal of Immunology, Molecular Therapy — Oncolytics and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.